These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1889309)

  • 21. Impact of pH and cationic supplementation on in vitro postantibiotic effect.
    Gudmundsson A; Erlendsdottir H; Gottfredsson M; Gudmundsson S
    Antimicrob Agents Chemother; 1991 Dec; 35(12):2617-24. PubMed ID: 1810197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [In vitro comparison of ciprofloxacin with other antibiotics against multiresistant gram-negative bacilli].
    Soto Hernández JL; Angeles Morales V; Perea Mejía B; Hernández Velázquez M; Martínez Zubieta R; Pasquel Rivera C
    Rev Invest Clin; 1991; 43(4):318-22. PubMed ID: 1798865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sub-MIC ciprofloxacin effect on fimbrial production by uropathogenic Escherichia coli strains.
    Lo Bue AM; Geremia E; Castagna C; Chisari G; Nicoletti G
    J Chemother; 1999 Oct; 11(5):357-62. PubMed ID: 10632381
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Investigation of the effect of efflux pump inhibitors to MIC values of ciprofloxacin in clinical isolates of Pseudomonas aeruginosa, Escherichia coli, Acinetobacter baumannii and Staphylococcus aureus].
    Cetinkaya E; Coban AY; Durupinar B
    Mikrobiyol Bul; 2008 Oct; 42(4):553-61. PubMed ID: 19149076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human Bile Reduces Antimicrobial Activity of Selected Antibiotics against Enterococcus faecalis and Escherichia coli
    Wulkersdorfer B; Jaros D; Eberl S; Poschner S; Jäger W; Cosentini E; Zeitlinger M; Schwameis R
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559254
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of efflux pump inhibitor 1-(1-naphthylmethyl)-piperazine to MIC values of ciprofloxacin in ciprofloxacin resistant gram-negative bacteria].
    Coban AY; Bayram Z; Sezgin FM; Durupinar B
    Mikrobiyol Bul; 2009 Jul; 43(3):457-61. PubMed ID: 19795621
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contributions of post-antibiotic lag and repair-recovery to the post-antibiotic effects of ciprofloxacin on Escherichia coli, Klebsiella pneumoniae, Staphylococcus aureus and Streptococcus pyogenes.
    Howard BM; Pinney RJ; Smith JT
    Chemotherapy; 1993; 39(1):22-31. PubMed ID: 8444058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Flow cytometric investigation of filamentation, membrane patency, and membrane potential in Escherichia coli following ciprofloxacin exposure.
    Wickens HJ; Pinney RJ; Mason DJ; Gant VA
    Antimicrob Agents Chemother; 2000 Mar; 44(3):682-7. PubMed ID: 10681338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacodynamic effects of ciprofloxacin, fleroxacin and lomefloxacin in vivo and in vitro.
    Fuentes F; Martín MM; Izquierdo J; Gomez-Lus ML; Prieto J
    Chemotherapy; 1996; 42(5):354-62. PubMed ID: 8874975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of pH on the postantibiotic effect (PAE) of netilmicin against Staphylococcus aureus and Escherichia coli.
    Minguez F; Gòmez-Lus ML; Ballestero S; Prieto J
    J Chemother; 1989 Jul; 1(4 Suppl):181-3. PubMed ID: 16312359
    [No Abstract]   [Full Text] [Related]  

  • 31. Target site antimicrobial activity of colistin might be misestimated if tested in conventional growth media.
    Matzneller P; Strommer S; Österreicher Z; Mitteregger D; Zeitlinger M
    Eur J Clin Microbiol Infect Dis; 2015 Oct; 34(10):1989-94. PubMed ID: 26178070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative pharmacodynamics of the new fluoroquinolone ABT492 and ciprofloxacin with Escherichia coli and Pseudomonas aeruginosa in an in vitro dynamic model.
    Zinner SH; Vostrov SN; Alferova IV; Lubenko IY; Portnoy YA; Firsov AA
    Int J Antimicrob Agents; 2004 Aug; 24(2):173-7. PubMed ID: 15288317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of a microplate method for determining the post-antibiotic effect in Staphylococcus aureus and Escherichia coli.
    Stubbings WJ; Bostock JM; Ingham E; Chopra I
    J Antimicrob Chemother; 2004 Jul; 54(1):139-43. PubMed ID: 15150167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of imipenem on Escherichia coli studied using bioluminescence, viable counting and microscopy.
    Hanberger H; Svensson E; Nilsson M; Nilsson LE; Hörnsten EG; Maller R
    J Antimicrob Chemother; 1993 Feb; 31(2):245-60. PubMed ID: 8463170
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Postantibiotic effects of eleven antimicrobials on five bacteria.
    Wang MG; Zhang YY; Zhu DM; Zhang J; Shi YG
    Acta Pharmacol Sin; 2001 Sep; 22(9):804-8. PubMed ID: 11749860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Investigation of the effects of efflux pump inhibitors on ciprofloxacin MIC values of high level fluoroquinolone resistant Escherichia coli clinical isolates].
    Coban AY; Birinci A; Ekinci B; Durupinar B
    Mikrobiyol Bul; 2004; 38(1-2):21-5. PubMed ID: 15293898
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic and ultrastructural effects induced by ciprofloxacin in Staphylococcus aureus during the postantibiotic effect (PAE) phase.
    Gottfredsson M; Erlendsdóttir H; Kolka R; Gudmundsson S
    Scand J Infect Dis Suppl; 1990; 74():124-8. PubMed ID: 2097700
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of low-level fluoroquinolone resistance genes qnrA1, qnrB19 and qnrS1 on ciprofloxacin treatment of isogenic Escherichia coli strains in a murine urinary tract infection model.
    Jakobsen L; Cattoir V; Jensen KS; Hammerum AM; Nordmann P; Frimodt-Møller N
    J Antimicrob Chemother; 2012 Oct; 67(10):2438-44. PubMed ID: 22685162
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ascorbate and Antibiotics, at Concentrations Attainable in Urine, Can Inhibit the Growth of Resistant Strains of
    Amábile-Cuevas CF
    Antibiotics (Basel); 2023 May; 12(6):. PubMed ID: 37370304
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postantibiotic effect, and postantibiotic effect of subinhibitory concentrations, of sparfloxacin on gram-negative bacteria.
    Odenholt-Tornqvist I; Bengtsson S
    Chemotherapy; 1994; 40(1):30-6. PubMed ID: 8306813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.